| Page 179 | Kisaco Research

This panel session will examine legal nuances when promoting innovation and collaboration whilst at the same time safeguarding proprietary information

- Indemnification: Best practice for incorporating trade secret clauses
- Internal training: How to emphasis training, reporting and enhanced ethical behaviours
- Successfully establish a risk mitigation framework when collaborating with another party and ensuring reasonable measures are taken to protect your trade secret.

Author:

Stephen Bychowski

Assistant General Counsel
Sanofi

Stephen Bychowski

Assistant General Counsel
Sanofi

Author:

Will Cottrell

Executive Director IP Licencing
RTX

Will Cottrell

Executive Director IP Licencing
RTX

Author:

Jeff Pade

Partner
Paul Hastings LLP

Jeff Pade

Partner
Paul Hastings LLP

Author:

Kelly Burke

Associate Senior Legal Counsel- IP Investigations
Adobe

Kelly Burke is Associate Senior Legal Counsel, IP Investigations at Adobe, where she focuses on IP investigations and protection, and leads the Trade Secret Protection Program.  Prior to that, she was Senior Security Counsel at Apple, concentrating on insider threats.  Before she went in-house, she was a prosecutor for more than a decade at the San Francisco District Attorney’s Office, where she specialized in trying complex white collar, public corruption, and public integrity criminal cases.

Kelly Burke

Associate Senior Legal Counsel- IP Investigations
Adobe

Kelly Burke is Associate Senior Legal Counsel, IP Investigations at Adobe, where she focuses on IP investigations and protection, and leads the Trade Secret Protection Program.  Prior to that, she was Senior Security Counsel at Apple, concentrating on insider threats.  Before she went in-house, she was a prosecutor for more than a decade at the San Francisco District Attorney’s Office, where she specialized in trying complex white collar, public corruption, and public integrity criminal cases.

Author:

Diane Fiddle

General Counsel
Qloo

Diane Fiddle

General Counsel
Qloo

Author:

Julie Lappin

Senior IP Counsel
Nestle

Julie is a Senior IP Counsel at Nestlé S.A. She has worked for multiple business units in her 14+ year career with Nestlé, including Coffee, Nestlé Health Science, and PetCare. Julie significantly contributed to developing and deploying Nestlé's trade secret protection program. Before joining Nestle, she was a Corporate Patent Counsel at Pfizer Inc.

Julie Lappin

Senior IP Counsel
Nestle

Julie is a Senior IP Counsel at Nestlé S.A. She has worked for multiple business units in her 14+ year career with Nestlé, including Coffee, Nestlé Health Science, and PetCare. Julie significantly contributed to developing and deploying Nestlé's trade secret protection program. Before joining Nestle, she was a Corporate Patent Counsel at Pfizer Inc.

Author:

Damon Gupta

Director, Patent Counsel
Spark Therapeutics, Inc

Damon Gupta is a Director, Patent Counsel at Spark Therapeutics, Inc., a leader in gene therapy and member of the Roche Group. With over a decade of experience in intellectual property (IP) law and a background in molecular biology, Damon advises biotechnology and pharmaceutical companies on patent strategy, IP transactions, and risk mitigation. At Spark, Damon leads efforts to protect proprietary assets, including trade secrets, manage IP disputes, and provides IP support to cross-functional teams, including R&D, manufacturing, and corporate transactions. Damon holds a J.D. from Chicago-Kent College of Law, an M.S. from Baylor College of Medicine, and a B.S. from The Ohio State University.

Damon Gupta

Director, Patent Counsel
Spark Therapeutics, Inc

Damon Gupta is a Director, Patent Counsel at Spark Therapeutics, Inc., a leader in gene therapy and member of the Roche Group. With over a decade of experience in intellectual property (IP) law and a background in molecular biology, Damon advises biotechnology and pharmaceutical companies on patent strategy, IP transactions, and risk mitigation. At Spark, Damon leads efforts to protect proprietary assets, including trade secrets, manage IP disputes, and provides IP support to cross-functional teams, including R&D, manufacturing, and corporate transactions. Damon holds a J.D. from Chicago-Kent College of Law, an M.S. from Baylor College of Medicine, and a B.S. from The Ohio State University.

Author:

John Williamson

Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

John Williamson is a partner in Finnegan’s D.C. office.  He advises companies on protecting and enforcing their intellectual property, with a strong focus on trade secrets and patent litigation. With more than 20 years of experience, John has represented clients in complex disputes before federal and state courts, the U.S. International Trade Commission, arbitration panels, and the U.S. Court of Appeals for the Federal Circuit. John works closely with in-house legal teams to develop IP strategies that align with business goals and mitigate risk. His practice includes trade secret investigations, litigation preparedness, and counseling on technical standards, economic exposure, and freedom-to-operate issues. He also supports clients in building and managing IP portfolios, helping them navigate competitive landscapes and protect proprietary technologies across a range of industries.

John Williamson

Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

John Williamson is a partner in Finnegan’s D.C. office.  He advises companies on protecting and enforcing their intellectual property, with a strong focus on trade secrets and patent litigation. With more than 20 years of experience, John has represented clients in complex disputes before federal and state courts, the U.S. International Trade Commission, arbitration panels, and the U.S. Court of Appeals for the Federal Circuit. John works closely with in-house legal teams to develop IP strategies that align with business goals and mitigate risk. His practice includes trade secret investigations, litigation preparedness, and counseling on technical standards, economic exposure, and freedom-to-operate issues. He also supports clients in building and managing IP portfolios, helping them navigate competitive landscapes and protect proprietary technologies across a range of industries.

DLP software detects potential data breaches/data exfiltration transmissions and prevents them by monitoring, detecting and blocking sensitive data

- How DLP tools work, capabilities, drawbacks, and costs.
- Can DLP tools form part of the reasonable steps that the company takes to protect its trade secrets
- Examine the intersection between DLP tools and legal arguments for future litigation scenarios

As companies continuously face threats to trade secrets leakage, there is growing recognition that protecting these valuable assets requires a collaborative approach. By uniting a cross disciplinary teams within an organization and ensure that trade secret protection is integrated into every aspect of the business—from legal and technical to operational and strategic levels.

- Understand the key roles and responsibilities of different departments (legal, cybersecurity, HR, R&D, leadership) in trade secret protection.
- Learn how to create an effective cross-functional working group to collaborate on trade secret initiatives.
- Discover strategies for building organizational alignment and fostering cooperation between legal and technical teams.
- Learn how to integrate trade secret protection into everyday business operations and company culture.

Author:

Kelly Burke

Associate Senior Legal Counsel- IP Investigations
Adobe

Kelly Burke is Associate Senior Legal Counsel, IP Investigations at Adobe, where she focuses on IP investigations and protection, and leads the Trade Secret Protection Program.  Prior to that, she was Senior Security Counsel at Apple, concentrating on insider threats.  Before she went in-house, she was a prosecutor for more than a decade at the San Francisco District Attorney’s Office, where she specialized in trying complex white collar, public corruption, and public integrity criminal cases.

Kelly Burke

Associate Senior Legal Counsel- IP Investigations
Adobe

Kelly Burke is Associate Senior Legal Counsel, IP Investigations at Adobe, where she focuses on IP investigations and protection, and leads the Trade Secret Protection Program.  Prior to that, she was Senior Security Counsel at Apple, concentrating on insider threats.  Before she went in-house, she was a prosecutor for more than a decade at the San Francisco District Attorney’s Office, where she specialized in trying complex white collar, public corruption, and public integrity criminal cases.

Author:

Julie Lappin

Senior IP Counsel
Nestle

Julie is a Senior IP Counsel at Nestlé S.A. She has worked for multiple business units in her 14+ year career with Nestlé, including Coffee, Nestlé Health Science, and PetCare. Julie significantly contributed to developing and deploying Nestlé's trade secret protection program. Before joining Nestle, she was a Corporate Patent Counsel at Pfizer Inc.

Julie Lappin

Senior IP Counsel
Nestle

Julie is a Senior IP Counsel at Nestlé S.A. She has worked for multiple business units in her 14+ year career with Nestlé, including Coffee, Nestlé Health Science, and PetCare. Julie significantly contributed to developing and deploying Nestlé's trade secret protection program. Before joining Nestle, she was a Corporate Patent Counsel at Pfizer Inc.

Author:

Diane Fiddle

General Counsel
Qloo

Diane Fiddle

General Counsel
Qloo

Author:

Damon Gupta

Director, Patent Counsel
Spark Therapeutics, Inc

Damon Gupta is a Director, Patent Counsel at Spark Therapeutics, Inc., a leader in gene therapy and member of the Roche Group. With over a decade of experience in intellectual property (IP) law and a background in molecular biology, Damon advises biotechnology and pharmaceutical companies on patent strategy, IP transactions, and risk mitigation. At Spark, Damon leads efforts to protect proprietary assets, including trade secrets, manage IP disputes, and provides IP support to cross-functional teams, including R&D, manufacturing, and corporate transactions. Damon holds a J.D. from Chicago-Kent College of Law, an M.S. from Baylor College of Medicine, and a B.S. from The Ohio State University.

Damon Gupta

Director, Patent Counsel
Spark Therapeutics, Inc

Damon Gupta is a Director, Patent Counsel at Spark Therapeutics, Inc., a leader in gene therapy and member of the Roche Group. With over a decade of experience in intellectual property (IP) law and a background in molecular biology, Damon advises biotechnology and pharmaceutical companies on patent strategy, IP transactions, and risk mitigation. At Spark, Damon leads efforts to protect proprietary assets, including trade secrets, manage IP disputes, and provides IP support to cross-functional teams, including R&D, manufacturing, and corporate transactions. Damon holds a J.D. from Chicago-Kent College of Law, an M.S. from Baylor College of Medicine, and a B.S. from The Ohio State University.

One of the biggest hurdles facing the Data Act’s implementation lies in finding the right balance between free access to data and protection of the trade secrets of manufacturers or data holders

- How the viewing data as trade secret?
- Examine trade secret provisions.
- How is this interpreted.
- How are other interpreted.
- What kinds of provisions
- How to trade secret data? Can raw data be a trade secret?

Author:

Arian Hassanalizadeh

General Counsel & Chief Compliance Officer
Origin

Arian Hassanalizadeh

General Counsel & Chief Compliance Officer
Origin

Author:

Hannah Joseph

Senior Director of Trade Secret
Regeneron

Hannah T. Joseph serves as Director of Trade Secrets at Regeneron Pharmaceuticals, Inc. At Regeneron, she drives strategy for the protection of trade secrets and proprietary information. Before joining Regeneron, Hannah worked at Beck Reed Riden LLP, a boutique law firm in Boston,  where she specialized in the areas of trade secrets law, restrictive covenants, and employee mobility for nearly a decade. Hannah holds a Juris Doctor from Boston College Law School and a Bachelor of Arts from Binghamton University.

Hannah Joseph

Senior Director of Trade Secret
Regeneron

Hannah T. Joseph serves as Director of Trade Secrets at Regeneron Pharmaceuticals, Inc. At Regeneron, she drives strategy for the protection of trade secrets and proprietary information. Before joining Regeneron, Hannah worked at Beck Reed Riden LLP, a boutique law firm in Boston,  where she specialized in the areas of trade secrets law, restrictive covenants, and employee mobility for nearly a decade. Hannah holds a Juris Doctor from Boston College Law School and a Bachelor of Arts from Binghamton University.

Protecting Trade Secrets: Iron-Clad Strategies for Employee Onboarding and Offboarding

Onboarding Strategies:
- Creating clear communication of the company’s trade secret policies and the legal implications of breaches.
- Design mandatory training sessions focused on data security and confidentiality.
- Drafting confidentiality agreements that reinforce the employee’s commitment to protecting sensitive information.

Offboarding Strategies:
- How to effective exit interview to solidify departing employee of their confidentiality obligations.
- Determine when and best approach for revoking access to all company systems and retrieving company-issued devices.
- How to ensure the return or destruction of any physical or digital copies of sensitive information.
- Continuous monitoring the former employee’s activities post-departure to detect any potential data breaches.

Legal Considerations and Enforcement:
- Discuss consequences of trade secret violations in employment contracts and company policies.
- How to take swift and decisive action against any breaches

Author:

James Gale

Co-Chair (IP Litigation)
Cozen O'Connor

James Gale

Co-Chair (IP Litigation)
Cozen O'Connor

Author:

Ronald Sia Deputy GC

Technology & Brand; Enterprise Risk & ESG Compliance Officer
SimpliSafe

Ron serves as Deputy General Counsel - Technology and Brand, and Enterprise Risk and Sustainability Compliance Officer for SimpliSafe.  Prior to joining SimpliSafe, he spent over a decade in a variety of in house legal roles at P&G / Gillette in Cincinnati and Boston, with his last role as Global Lead Commercial Counsel for the Gillette business unit.  Ron studied Chemical Engineering and Economics at Tufts University and received his JD from UNH School of Law.

Ronald Sia Deputy GC

Technology & Brand; Enterprise Risk & ESG Compliance Officer
SimpliSafe

Ron serves as Deputy General Counsel - Technology and Brand, and Enterprise Risk and Sustainability Compliance Officer for SimpliSafe.  Prior to joining SimpliSafe, he spent over a decade in a variety of in house legal roles at P&G / Gillette in Cincinnati and Boston, with his last role as Global Lead Commercial Counsel for the Gillette business unit.  Ron studied Chemical Engineering and Economics at Tufts University and received his JD from UNH School of Law.

Author:

Amanda Betman

Employment Law Executive Director
Novartis

Amanda Betman

Employment Law Executive Director
Novartis

Author:

Barry Golob

Co-Chair
Cozen O’Connor

Barry Golob

Co-Chair
Cozen O’Connor

- Different rationale on whether you can log trade secret IP?
 Differences in industries?
 How companies operate that may provide different rationale
- What variables are available to track their trade secret?
- How their industries operate,
- Examine examples of cost/benefits of trade secret tracking
- How to effectively mark, catalogue trade secret – to avoid litigation
 What tools and controls are available.
 How many categories do you use?
- How do you define different sensitivity issue and audits.

Author:

Shane O`Neill

Legal Director
Riyadh Air

Shane O’Neill trained and qualified as a competition lawyer at Freshfields Bruckhaus Deringer where he advised clients in the aerospace and aviation sectors on merger control and antitrust regulatory matters. Since moving in-house he has advised on a broad range of matters including IT outsourcing, IP licensing, data protection, IPO, cybersecurity, commercial negotiations with aerospace OEMS, corporate transactions, and IP strategy. 

Currently, he is Assistant General Counsel at Norsk Titanium, a global leader in metal 3D printing which supplies components to the aerospace, defence, and industrial sectors. He is responsible for a number of corporate areas including driving the company’s IP strategy, creation of IP awareness, trade secret protection, IP portfolio management, IP risk reduction, IP collaboration and cybersecurity.

Shane O`Neill

Legal Director
Riyadh Air

Shane O’Neill trained and qualified as a competition lawyer at Freshfields Bruckhaus Deringer where he advised clients in the aerospace and aviation sectors on merger control and antitrust regulatory matters. Since moving in-house he has advised on a broad range of matters including IT outsourcing, IP licensing, data protection, IPO, cybersecurity, commercial negotiations with aerospace OEMS, corporate transactions, and IP strategy. 

Currently, he is Assistant General Counsel at Norsk Titanium, a global leader in metal 3D printing which supplies components to the aerospace, defence, and industrial sectors. He is responsible for a number of corporate areas including driving the company’s IP strategy, creation of IP awareness, trade secret protection, IP portfolio management, IP risk reduction, IP collaboration and cybersecurity.

Author:

Erica LoRe

Senior Director, Intellectual Property Counsel
Invivyd

Erica LoRe

Senior Director, Intellectual Property Counsel
Invivyd

Author:

Wil Rao

Patent Attorney
McAndrews, Held & Malloy, Ltd

Wil Rao

Patent Attorney
McAndrews, Held & Malloy, Ltd

Author:

Laurence Shumway

Vice President, Intellectual Property Counsel
Flagship Pioneering

Larry Shumway joined Flagship Pioneering in 2018 and serves as Vice President, Intellectual Property Counsel. He is responsible for developing, implementing, and managing IP and related legal strategies for Flagship’s enterprise companies, as well as setting institutional policies and designing educational courses.

He has more than 15 years of industry and law firm experience, specializing in biologics and biotechnology. As inhouse counsel at Takeda, GSK, and Novartis, he designed and managed complex IP portfolios around innovative large molecule platforms and assets in oncology, immunology, and vaccines, and led IP and legal functions on transactional and project teams. He began his legal career in the IP boutique firms of Hamilton, Brook, Smith and Reynolds, PC and Finnegan, LLP, focusing on evaluating and protecting complex biologics and inventions at the interface of biology with different technical fields.

Larry studied law at Boston College (J.D.) and earned his Ph.D. in biophysics from Harvard University on an NSF fellowship. He earned B.S. degrees in biochemistry and molecular biology and in mathematics and statistics from the University of Massachusetts, Amherst, on Goldwater, Beckman, and Pfizer scholarships.

Laurence Shumway

Vice President, Intellectual Property Counsel
Flagship Pioneering

Larry Shumway joined Flagship Pioneering in 2018 and serves as Vice President, Intellectual Property Counsel. He is responsible for developing, implementing, and managing IP and related legal strategies for Flagship’s enterprise companies, as well as setting institutional policies and designing educational courses.

He has more than 15 years of industry and law firm experience, specializing in biologics and biotechnology. As inhouse counsel at Takeda, GSK, and Novartis, he designed and managed complex IP portfolios around innovative large molecule platforms and assets in oncology, immunology, and vaccines, and led IP and legal functions on transactional and project teams. He began his legal career in the IP boutique firms of Hamilton, Brook, Smith and Reynolds, PC and Finnegan, LLP, focusing on evaluating and protecting complex biologics and inventions at the interface of biology with different technical fields.

Larry studied law at Boston College (J.D.) and earned his Ph.D. in biophysics from Harvard University on an NSF fellowship. He earned B.S. degrees in biochemistry and molecular biology and in mathematics and statistics from the University of Massachusetts, Amherst, on Goldwater, Beckman, and Pfizer scholarships.